John Paulson portfolio, Q1 2026

Paulson & Co. · 13F for the quarter ending Mar 31, 2026

For Q1 2026, Paulson & Co. reported $3.1B across 9 US-listed positions, led by PPTA (29.2%), MDGL (23.4%) and AAMI (13.5%). Compared with its filing for Q4 2025, John Paulson opened 1 new position, added to 2, reduced 1 and sold out of 1; 5 positions did not change.

The largest purchase was an addition to THM ($67.5M); the largest sale, a reduction of MDGL ($165.1M).

Reported value
$3.1B
Positions
9
In the top 10
100%
Filed
May 15
2026

Key facts

13F portfolio value
$3.1BQ1 2026
Positions
9
Largest holding
PPTA 29.2%
New positions
1
Sold out
1
Filed
May 15, 2026

Holdings as of (Q1 2026), filed with the SEC on . Changes are measured against the filing for Dec 31, 2025. Every tracked investor's Q1 2026 13F.

Bought and sold in Q1 2026

John Paulson: buys and sells in Q1 2026
StockMoveSharesSizeOf portfolio
Madrigal Pharmaceuticals IncMDGL▼ Reduced 18%−315.33K$165.1M5.30%
Solstice Advanced Matls IncSOLS▼ Sold out−1.4M$67.8M2.18%
International Tower Hill MinTHM▲ Added 42%+29.33M$67.5M2.17%
Thryv Holdings IncTHRY▲ Added 94%+4.1M$11.2M0.36%
Amicus Therapeuticno ticker on file
▲ New+32.4K$468.5K0.02%

Holdings at the quarter's end

John Paulson holdings, Q1 2026
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q4 2025
1Perpetua Resources CorpPPTA—29.2%$909.6M32.35M$28.128+ qtrsNo change
2Madrigal Pharmaceuticals IncMDGLHealth Care23.4%$728.8M1.39M$523.478+ qtrs▼ Reduced 18%
3Acadian Asset Management IncAAMI—13.5%$421.4M7.74M$54.428+ qtrsNo change
4Bausch Health Cos IncBHC—12.7%$395.6M73.26M$5.408+ qtrsNo change
5Novagold Resources IncNG—7.86%$244.6M27.24M$8.988+ qtrsNo change
6International Tower Hill MinTHM—7.36%$229M99.57M$2.308+ qtrs▲ Added 42%
7Agnico Eagle Mines LtdAEMMaterials5.11%$159M783.56K$202.988+ qtrsNo change
8Thryv Holdings IncTHRY—0.74%$23.1M8.44M$2.748+ qtrs▲ Added 94%
9
Amicus Therapeuticno ticker on file
—0.02%$468.5K32.4K$14.461 qtrNew

By sector

John Paulson portfolio by sector, Q1 2026
SectorShare of portfolioValuePositions
Health Care23.4%$728.8M1
Materials5.11%$159M1
No sector on file71.5%$2.2B7

Questions and answers

What did John Paulson own in Q1 2026?

Paulson & Co.'s 13F for Q1 2026 lists 9 positions worth $3.1B. The largest: PPTA (29.2%), MDGL (23.4%), AAMI (13.5%), BHC (12.7%), NG (7.9%).

What did John Paulson buy in Q1 2026?

The largest purchases, by the shares bought at the quarter-end price the filing implies: THM (added, $67.5M), THRY (added, $11.2M), Amicus Therapeutic (new, $468.5K).

What did John Paulson sell in Q1 2026?

The largest sales: MDGL (reduced, $165.1M), SOLS (sold out, $67.8M).

When was this filing made?

Paulson & Co. filed its 13F for the quarter ending Mar 31, 2026 on May 15, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “John Paulson portfolio, Q1 2026: Paulson & Co. 13F holdings”, data as of 15 May 2026. https://funkfolio.com/gurus/john-paulson/2026-q1

Underlying data: SEC EDGAR, Form 13F-HR of Paulson & Co. (CIK 1035674) for the period ending Mar 31, 2026.

Source: SEC EDGAR, Form 13F-HR for Paulson & Co. (CIK 1035674), period ending Mar 31, 2026, filed May 15, 2026. Changes compare share counts with the filing for Dec 31, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $3.1B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 8 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.